Table 3.
Plasma concentrations of selected proinflammatory factors in patients with MM.
| Untreated Group without PN (n = 59) |
Treated Group with PN (n = 34) | Treated Group without PN (n = 27) |
p-Value * Treated Group with PN vs. Untreated Group without PN |
p-Value * Treated Group without PN vs. Untreated Group without PN |
p-Value * Treated Group with PN vs. Treated Group without PN |
|
|---|---|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ± SD | ||||
| TNF-α (pg/mL) | 4.44 ± 2.71 | 3.84 ± 2.05 | 3.55 ± 2.32 | 0.3222 | 0.0428 | 0.2327 |
| IL-6 (pg/mL) | 4.48 ± 8.32 | 3.04 ± 2.73 | 2.77 ± 2.25 | 0.9300 | 0.9221 | 0.9593 |
| Chitinase3 (pg/mL) | 59,018 ± 39,791.33 | 50,706 ± 33,595.14 | 40,502 ± 27,212.7 | 0.4437 | 0.0346 | 0.2013 |
| IL-10 (pg/mL) | 3.44 ± 7.00 | 2.07 ± 0.83 | 1.64 ± 0.34 | 0.9554 | 0.005 | 0.0017 |
| CCL2 (pg/mL) | 190.94 ± 81.88 | 299.24 ± 165.30 | 252.41 ± 91.15 | 0.0018 | 0.002 | 0.4458 |
| IL-1β (pg/mL) | 1.28 ± 0.48 | 1.93 ± 0.35 | 1.70 ± 0.48 | <0.0001 | <0.0001 | 0.0023 |
| IFN-γ (pg/mL) | 2.79 ± 1.50 | 14.40 ± 8.03 | 11.76 ± 3.19 | <0.0001 | <0.0001 | 0.2659 |
* Mann–Whitney test. In bold, p-values < 0.05.